Profile
Daniel D. Shoemaker holds the position of Chief Scientific Officer for Fate Therapeutics, Inc. He previously was Chief Scientific Officer at ICX Biosystem, Chief Scientific Officer at GHC Technologies, Inc. and Director-Target Discovery at Merck Research Laboratories Massachusetts LLC. Dr. Shoemaker received a doctorate from Stanford University and an undergraduate degree from the University of California, Santa Barbara.
Former positions of Daniel Shoemaker
Companies | Position | End |
---|---|---|
FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-06-29 |
ICX Biosystem | Chief Tech/Sci/R&D Officer | 2008-12-31 |
GHC Technologies, Inc.
GHC Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services GHC Technologies, Inc. develops technologies for information-rich molecular diagnosis. Its research and development efforts enable commercial partners to develop clinical diagnostic products. The company was founded by Roland Stoughton in 2004 and is headquartered in Wilsonville, OR. | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 2002-12-31 |
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Director/Board Member | - |
Training of Daniel Shoemaker
Stanford University | Doctorate Degree |
University of California, Santa Barbara | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
GHC Technologies, Inc.
GHC Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services GHC Technologies, Inc. develops technologies for information-rich molecular diagnosis. Its research and development efforts enable commercial partners to develop clinical diagnostic products. The company was founded by Roland Stoughton in 2004 and is headquartered in Wilsonville, OR. | Commercial Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
ICX Biosystem |